• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Monopar Therapeutics Inc. - Common Stock (NQ:MNPR)

    41.96 +1.15 (+2.82%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 29, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 19,071
    Open 40.37
    Bid (Size) 39.77 (10)
    Ask (Size) 44.10 (1)
    Prev. Close 40.81
    Today's Range 39.62 - 42.00
    52wk Range 1.719 - 54.30
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments
    From Monopar Therapeutics Inc.
    Via GlobeNewswire

    Performance

    YTD
    +88.8%
    +88.8%
    1 Month
    +15.2%
    +15.2%
    3 Month
    +0.3%
    +0.3%
    6 Month
    +158.9%
    +158.9%
    1 Year
    +1191.1%
    +1191.1%

    More News

    Read More
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    Monopar to Present at the 36th Annual Piper Sandler Healthcare Conference
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    3 Momentum Stocks Soaring Into 2025 and Beyond
    Via MarketBeat
    Topics Stocks
    Exposures US Equities
    Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    MarketBeat Week in Review – 10/21- 10/25
    Via MarketBeat
    Topics Artificial Intelligence Economy Stocks
    Exposures Artificial Intelligence Economy Interest Rates
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    What's Going On With Monopar Therapeutics Shares Friday?
    Via Benzinga
    Monopar Therapeutics Skyrockets 400% on Licensing Deal
    Via MarketBeat
    Exposures COVID-19
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Monopar Therapeutics, Intellia Therapeutics, Capri Holdings, Western Digital, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Monopar Therapeutics Stock Jumps 4X, Inks Licensing Pact With AstraZeneca For Once Terminated Phase 3 Candidate For Rare Genetic Disorder
    Via Benzinga
    Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    Monopar Presents Encouraging Human Clinical Dosimetry Data on its uPAR Program at EANM 2024
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    Monopar Expands Radiopharma Intellectual Property Portfolio with Patent Filing on New Compounds and Linkers
    From Monopar Therapeutics Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Monopar Therapeutics Inc. - Common Stock publicly traded?
    Yes, Monopar Therapeutics Inc. - Common Stock is publicly traded.
    What exchange does Monopar Therapeutics Inc. - Common Stock trade on?
    Monopar Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Monopar Therapeutics Inc. - Common Stock?
    The ticker symbol for Monopar Therapeutics Inc. - Common Stock is MNPR on the Nasdaq Stock Market
    What is the current price of Monopar Therapeutics Inc. - Common Stock?
    The current price of Monopar Therapeutics Inc. - Common Stock is 41.96
    When was Monopar Therapeutics Inc. - Common Stock last traded?
    The last trade of Monopar Therapeutics Inc. - Common Stock was at 04/29/25 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.